Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) — Cash Flow Reinvestment Rate
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (ONCSM) has a Cash Flow Reinvestment Rate of 0.18x as of September 2024, reinvesting TL5.93 Million (capex TL2.91 Million plus investments TL-3.03 Million) from operating cash flow of TL33.37 Million. Check ONCSM cash flow quality score to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. Cash Flow Reinvestment Rate (2020–2022)
Historical reinvestment intensity for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. across 3 annual periods. Explore Oncosem Onkolojik Sistemler Sanayi ve Ti debt service capacity to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S. (2020–2022)
Year-by-year capital reinvestment analysis for Oncosem Onkolojik Sistemler Sanayi ve Ticaret A.S.. For live market cap and broader valuation context, see ONCSM company net worth.
| Year | Reinvestment Rate | Total Reinvested (TRY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.01x | TL53.09 Million | TL52.69 Million | TL26.02 Million | ▲ +38.0% |
| 2021 | 0.73x | TL37.73 Million | TL51.68 Million | TL0.00 | ▼ -12.7% |
| 2020 | 0.84x | TL16.23 Million | TL19.41 Million | TL0.00 | — |